PKBK vs RARE · P/E 8.9, rev $75.4M vs rev $350.0M
Parke Bancorp Inc (PKBK) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Parke Bancorp Inc (PKBK) is a banks - regional company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported PKBK revenue for 2026-06-30 was $75.4M. Net income was $24.1M. PKBK currently screens at market cap $254.4M and trailing P/E 8.9.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
PKBK currently screens at market cap $254.4M and trailing P/E 8.9. RARE currently screens at market cap $2.79B.
Not investment advice. Open the PKBK and RARE stock pages for the full models.
Not investment advice.